Recombinant Glycoprotein Vaccine for the Prevention of Genital HSV-2 Infection

1999485 citationsJournal Article

Authors

Lawrence Corey · Seattle University

Andria Langenberg

Abstract

Efficient and sustained protection from sexual acquisition of HSV-2 infection will require more than high titers of specific neutralizing antibodies. Protection against sexually transmitted viruses involving exposure over a prolonged period will require a higher degree of vaccine efficacy than that achieved in this study.

Topics & Keywords

Herpesvirus Infections and Treatments Hepatitis B Virus Studies Hepatitis Viruses Studies and Epidemiology

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JAMA

Volume 282, Issue 4, pp. 331-40

DOI: 10.1001/jama.282.4.331

Field-Weighted Citation Impact: 15.83